Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a88b96e9fc3920885a1c262504543934 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate |
2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd626be0417f420f207f59087ae7f3a7 |
publicationDate |
2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017194748-A1 |
titleOfInvention |
Medicament for treatment and/or prophylactic treatment of breast cancer |
abstract |
Disclosed herein is a composition comprising a 5-Alpha Reductase Inhibitor (5-ARI) and an excipient for use in the treatment and/or prophylactic treatment of breast cancer. |
priorityDate |
2016-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |